Stemmatters
1 known investors
Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.
Founders & leadership
Investors · 1
Competitors · 4
by search overlap
bio6 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
PAREXEL4 shared keywordsParexel is a clinical research organization that runs clinical trials for investigational medicines and supports pharmaceutical and biotech drug development. It works with patients participating in trials and with companies developing new drugs and therapies.
Fraunhofer IAO4 shared keywordsFraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.
Microbiotica4 shared keywordsMicrobiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment. The company uses a clinic-led discovery platform to identify specific bacteria linked to patient outcomes and target patient populations.
Companies competing with Stemmatters for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Stemmatters do?
- Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.
- Who are Stemmatters's investors?
- Stemmatters's investors include Beta Capital.